| Filed On | Filing |
|---|---|
| 15 Jul 2026 |
8-K/A: Results of Operations and Financial Condition
To the Shareholders and the Board of Directors of Cullgen Inc. |
| 17 Apr 2026 |
8-K/A: Entry into a Material Definitive Agreement
The second full paragraph in the Original Form 8-K is hereby amended and restated as follows: |
| 19 Jan 2024 |
8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule; Departure/Election of Directors or Officers; Compensation
THIS EMPLOYMENT AGREEMENT (this “Agreement”), dated as of January 15, 2024, by and between Gyre Therapeutics, Inc., a Delaware corporation (the “Company”), and Han Ying (the “Executive”). |
| 12 Jan 2024 |
8-K/A: Completion of Acquisition or Disposition of Assets
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. |
| 24 May 2022 | 8-K/A: Financial Statements and Exhibits |
| 23 Oct 2015 | 8-K/A: Financial Statements and Exhibits |
| 04 Sep 2015 | 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more |
Loading...
